Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis
Status:
Withdrawn
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
Treatment of primary hyperhidrosis through a comparative study between oxybutynin
hydrochloride and placebo.
Hydrochloride may decrease the symptoms of hyperhidrosis improving the subject's quality of
life.
Phase:
Phase 3
Details
Lead Sponsor:
Cristália Produtos Químicos Farmacêuticos Ltda.
Collaborators:
Hospital Israelita Albert Einstein University of Sao Paulo